EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Clinical Safety and Performance of GATT-Patch for Hemostasis in Minimal to Moderate Bleeding During Open Liver Surgery

Johannes H W de Wilt, Cornelis Verhoef, Marieke T de Boer, Martijn W J Stommel, Leanne van der Plas-Kemper, Linda M Garms, Charlène J van der Zijden, Stuart J Head, Johan C M E Bender, Harry van Goor, Robert J Porte

Journal of Surgical Research · 2024

DOI: 10.1016/j.jss.2024.03.033 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Surgical Research, 2024. Verfasst von Johannes H W de Wilt und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Hans.deWilt@radboudumc.nl. Hauptthemen laut MEDLINE: Hepatectomy, Blood Loss, Surgical. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Intraoperative blood loss and postoperative hemorrhage affect outcomes after liver resection. GATT-Patch is a new flexible, pliable hemostatic sealant patch comprising fibrous gelatin carrier impregnated with N-hydroxy-succinimide polyoxazoline. We evaluated safety and performance of the GATT-Patch for hemostasis at the liver resection plane. METHODS: Adult patients undergoing elective open liver surgery were recruited in three centers. GATT-Patch was used for minimal to moderate bleeding at the liver resection plane. The primary endpoint was hemostasis of the first-treated bleeding site at 3 min versus a prespecified performance goal of 65.4%. RESULTS: Two trial stages were performed: I (n = 8) for initial safety and II (n = 39) as the primary outcome cohort. GATT-Patch was applied in 47 patients on 63 bleeding sites. Median age was 60.0 (range 25-80) years and 70% were male. Most (66%) surgeries were for colorectal cancer metastases. The primary endpoint was met in 38 out of 39 patients (97.4%; 95% confidence interval: 84.6%-99.9%) versus 65.4% (P < 0.001). Of all the 63 bleeding sites, hemostasis was 82.7% at 30, 93.7% at 60, and 96.8% at 180 s. No reoperations for rebleeding or device-related issues occurred. CONCLUSIONS: When compared to a performance goal derived from state-of-the-art hemostatic agents, GATT-Patch for the treatment of minimal to moderate bleeding during liver surgery successfully and quickly achieved hemostasis with acceptable safety outcomes. (ClinicalTrials.gov Identifier: NCT04819945).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatectomyBlood Loss, SurgicalHumansMaleMiddle AgedFemaleAgedAdultAged, 80 and overHemostasis, SurgicalHemostaticsTreatment OutcomeGelatinProspective StudiesLiver Neoplasms

Stichwörter der Autor:innen

BleedingGATT-PatchHemostasisHepatectomyLiver surgery

Substanzen

HemostaticsGelatin

Autor:innen und Institutionen

  • Department of Surgical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Hans.deWilt@radboudumc.nl.
  • Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Department of HPB Surgery, University Medical Center Groningen, The Netherlands.
  • Department of Surgical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • GATT Technologies, Nijmegen, The Netherlands.

Zitieren

APA

de Wilt, J. H. W., Verhoef, C., de Boer, M. T., Stommel, M. W. J., van der Plas-Kemper, L., Garms, L. M., van der Zijden, C. J., Head, S. J., Bender, J. C. M. E., van Goor, H., & Porte, R. J. (2024). Clinical Safety and Performance of GATT-Patch for Hemostasis in Minimal to Moderate Bleeding During Open Liver Surgery. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2024.03.033

Vancouver

de Wilt JHW, Verhoef C, de Boer MT, Stommel MWJ, van der Plas-Kemper L, Garms LM, et al. Clinical Safety and Performance of GATT-Patch for Hemostasis in Minimal to Moderate Bleeding During Open Liver Surgery. Journal of Surgical Research. 2024. doi:10.1016/j.jss.2024.03.033

BibTeX
@article{deWilt2024,
  author = {de Wilt, Johannes H W and Verhoef, Cornelis and de Boer, Marieke T and Stommel, Martijn W J and van der Plas-Kemper, Leanne and Garms, Linda M and van der Zijden, Charlène J and Head, Stuart J and Bender, Johan C M E and van Goor, Harry and Porte, Robert J},
  title = {Clinical Safety and Performance of GATT-Patch for Hemostasis in Minimal to Moderate Bleeding During Open Liver Surgery},
  journal = {Journal of Surgical Research},
  year = {2024},
  doi = {10.1016/j.jss.2024.03.033}
}
Kostenlos starten →